ACT Brief: Diversity Built Into Trial Design, AI Impact Across Trial Lifecycle, and Companion Insights
Clinical trial diversity is essential for accurate cannabis research and effective patient care. Integrating AI enhances trial design and data analysis across the trial lifecycle. This approach ensures findings are relevant to diverse patient populations.
Scientists Create “Smart” DNA Drug Targeting Cancer Cells with Extreme Precision
Precision-targeted DNA therapeutics represent a potential paradigm shift in cancer treatment. This innovative approach focuses on molecular specificity to target cancer cells. Precision-targeted DNA therapeutics could reduce systemic toxicity compared to…
Cannabidiol in Developmental Epilepsy: Organoid-Guided Precision Medicine Across Critical Neurodevelopmental Windows.
CBD neurodevelopmental epilepsy research reveals promising precision medicine approaches targeting critical developmental windows. This review synthesizes evidence on CBD's neuroprotective and antiseizure effects in pediatric epilepsy. Understanding…
A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care
Digital therapeutics cannabinoid medicine offers new tools for precise symptom tracking and treatment adjustment in medical cannabis care. This framework supports individualized dosing and accountable therapeutic protocols. It helps close evidence gaps…
